Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

Kayoko Kikuchi, Yoshitaka Miyakawa, Shunya Ikeda, Yuji Sato, Toru Takebayashi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Fingerprint Dive into the research topics of 'Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults'. Together they form a unique fingerprint.

Medicine & Life Sciences